Adverse events associated with anticoagulation therapy in the periendoscopic period.

ABSTRACT:

Background

Chronic anticoagulation has been demonstrated to be a risk factor for GI bleeding (GIB) in patients undergoing endoscopic procedures.

Objective

The aim of this study was to determine the incidence of GIB prospectively in a large cohort of patients enrolled in the Clinical Outcomes Research Initiative (CORI) database.

Design

Anticoagulated patients undergoing endoscopic procedures were interviewed by phone 30 to 45 days after the procedure to determine potential adverse events and management of warfarin therapy in the periendoscopic period.

Setting

Participating CORI sites, Stanford University Hospital, Veterans Administration Palo Alto Health Care System.

Main outcome measurement

Postprocedural hemorrhagic or thrombotic events.

Results

SUBMITTER: Gerson LB 

PROVIDER: S-EPMC3848307 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature